Genmab A/S (GMAB)

Genmab Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018	2017
Cash & Equivalents	9,893	8,957	7,260	3,552	533	1,348
Short-Term Investments	12,431	10,381	8,819	7,419	5,573	4,075
Cash & Cash Equivalents	22,324	19,338	16,079	10,971	6,106	5,423
Cash Growth	15.44%	20.27%	46.56%	79.68%	12.60%	-
Receivables	5,760	3,394	2,483	3,001	1,337	587.76
Other Current Assets	134	4	229	-11	-10	48.93
Total Current Assets	28,218	22,736	18,791	13,961	7,433	6,059
Property, Plant & Equipment	1,322	975	736	414	162	113.42
Long-Term Investments	133	371	1,081	149	0	0
Goodwill and Intangibles	146	254	338	470	470	124.4
Other Long-Term Assets	300	291	197	150	396	305.71
Total Long-Term Assets	1,901	1,891	2,352	1,183	1,028	543.52
Total Assets	30,119	24,627	21,143	15,144	8,461	6,603
Accounts Payable	1,727	1,493	1,186	840	318	178.9
Deferred Revenue	513	513	513	0	0	150.65
Current Debt	74	62	42	26	0	0
Other Current Liabilities	-491	-500	-488	72	126	-2.43
Total Current Liabilities	1,823	1,568	1,253	938	444	327.12
Long-Term Debt	523	363	277	155	0	0
Other Long-Term Liabilities	491	500	492	3	3	3.63
Total Long-Term Liabilities	1,014	863	769	158	3	3.63
Total Liabilities	2,837	2,431	2,022	1,096	447	330.75
Total Debt	597	425	319	181	0	0
Debt Growth	40.47%	33.23%	76.24%	-	-	-
Retained Earnings	14,809	10,020	7,107	2,130	-198	-1,854.73
Shareholders' Equity	27,282	22,196	19,121	14,048	8,014	6,272
Net Cash / Debt	21,727	18,913	15,760	10,790	6,106	5,423
Net Cash / Debt Growth	14.88%	20.01%	46.06%	76.71%	12.60%	-
Working Capital	26,395	21,168	17,538	13,023	6,989	5,732
Book Value Per Share	41.44	33.83	29.38	21.85	12.46	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).